In a cohort of Karolinska memory clinic patients, plasma GFAP levels correlated significantly with PET-detected amyloid deposits, but not with measure of pTau in CSF, whereas plasma pTau isoforms were associated with both measures of amyloid and tau pathology [66]. The gene discussed is MAPT; the disease is amyloidosis.